Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 DISEASE NETWORK REGISTRY PROJECTS LOGIN
 
 
  
Wet Biomarkers -
--->Uutiset
[-]Projekti
--->Rahoittaja
--->[+]Johtokunta
--->[+]Writing Committee Strategic ...
--->[+]Neuvoa antava lautakunta
--->Keskuskoordinaatio
--->Kielikoordinaatio
--->Fellowship Programme
--->[+]Perustuslaki 2008
--->[+]Äänestys
--->[+]Jäsenet
[+]Tutkimuspaikat
[+]Työryhmät
[-]Tapahtumat
--->[+]EHDN 2016
--->EHDN 2014
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[-]EHDN 2010
--->Introduction
--->Programme I
--->Programme II
--->Additional Meetings
--->Registration
--->EHA Programme
--->[+]EHA Registration
--->Plenary Dinner
--->Social Programme
--->Important Dates
--->[+]Abstract Submission
--->Reimbursement
--->Hotel Booking
--->[+]Travel and Location
--->[+]About Prague
--->Documents
--->Committees
--->Contact
--->Feedback & Evaluation
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[+]Yhteydenpito
--->Työtarjoukset
päivämääräkuvauskokokirjoittaja asiakirja 
03.08.26Selisistat: potential pharmacodynamic readouts based on transcriptomics32 kBanonymousapplication/mswordf04-potential-pharmacodynamic-readouts 
03.08.26Mutant Huntingtin fragmentation in immune cells tracks Huntington’s Disease progression32 kBanonymousapplication/mswordf05-mutant-huntingtin-fragmentation 
03.08.26Whole blood SAGE digital gene expression profiling from Huntington's disease patients32 kBanonymousapplication/mswordf03-blood-sage-digital-gene-expression 
03.08.26Selisistat: Soluble htt protein levels as a potential pharmacodynamic readout32 kBanonymousapplication/mswordf02-soluble-htt-protein-levels 
03.08.26Establishment of novel assays for quantification of full-length wild-type and mutant Huntingtin by using the AlphaLISA technology32 kBanonymousapplication/mswordf01-establishment-novel-assays 
03.08.26A critical evaluation of inflammatory markers in Huntington’s Disease plasma32 kBanonymousapplication/mswordf06-critical-evaluation-inflammatory-m... 
03.08.26Cross-sectional and longitudinal associations between CRP and neuropsychiatric symptoms in HD32 kBanonymousapplication/mswordf07-crp-neuropsychiatric-symptoms 
03.08.26Abnormal regulation of macrophage-derived transforming growth factor – β 1 (TGF-β1) production in Huntington Disease32 kBanonymousapplication/mswordf12-abnormal-regulation-of-macrophage 
03.08.268OHdG is not a biomarker for Huntington’s Disease; lessons for future biomarker studies32 kBanonymousapplication/mswordf14-8ohdg 
03.08.26Progredient deterioration of hepatic mitochondrial function in Huntington's Disease – measured by using the 13C-methionin breath test32 kBanonymousapplication/mswordf11-progredient-deterioration-hepatic-... 
03.08.26The study on molecular changes related to energy metabolism in Huntington’s disease subjects - looking for biomarkers32 kBanonymousapplication/mswordf09-molecular-changes-related-to-energ... 
03.08.26The autoimmune profile of Huntington`s Disease patients - a pilot study32 kBanonymousapplication/mswordf08-autoimmune-profile 
03.08.26A new biomarker in Huntington's disease32 kBanonymousapplication/mswordf15-new-biomarker 

Kansio sisältää 13 asiakirjaa.
about us | privacy statement | disclaimer | terms of use